Diana Fernandes and Fernanda Andrade are part of a research team that developed an injectable hydrogel capable of enhancing the effectiveness of chemotherapy against solid tumors, potentially representing a revolution in how this treatment is currently administered.
The two Portuguese women wanted to "humanize" oncological treatment, seeking to significantly reduce the side effects that traditionally affect patients undergoing conventional chemotherapy.
The hydrogel developed by the team allows chemotherapy to be administered in a more targeted way, aiming to make side effects "minimal" for patients.
Solid tumors are the main target of this innovative therapeutic approach, including ovarian, brain, breast, and pancreatic cancers, types of cancer often difficult to treat with conventional methods.
